| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |